Autres langues

27/08 Perrigo to Attend the Barclays Global Consumer Conference
05/08 Perrigo Shares Rise After Fiscal Q2 Adjusted Earnings, Net Sales Beat Estimates
05/08 Perrigo Company plc Reports Earnings Results for the Second Quarter and Six Months Ended June 27, 2026
05/08 Perrigo Company plc Reaffirms Earnings Guidance for the Full-Year of 2026
05/08 (PRGO) Perrigo Expects 2026 Adjusted EPS Range $2.00 - $2.30, vs. FactSet Est of $2.12
05/08 Earnings Flash (PRGO) Perrigo Company plc Reports Q2 Revenue $1.02B, vs. FactSet Est of $1.01B
05/08 Earnings Flash (PRGO) Perrigo Company plc Posts Q2 Adjusted EPS $0.50 per Share, vs. FactSet Est of $0.34
05/08 Perrigo: Q2 Earnings Snapshot
05/08 Perrigo Reports Second Quarter 2026 Financial Results From Continuing Operations
30/07 Perrigo Announces Quarterly Dividend, Payable on September 15, 2026
30/07 Perrigo Announces Quarterly Dividend
29/07 Perrigo to Present at the Canaccord 46th Annual Growth Conference
22/07 Perrigo to Release Second Quarter 2026 Financial Results on August 5, 2026
30/06 Perrigo Announces Appointment of Two New Independent Directors to Board
30/06 Perrigo Company plc Announces Board Appointments, Effective June 30, 2026
29/06 Perrigo Company plc(NYSE:PRGO) added to Russell 2000 Index
29/06 Perrigo Company plc(NYSE:PRGO) dropped from Russell Midcap Value Benchmark
29/06 Perrigo Company plc(NYSE:PRGO) added to Russell 2000 Value Benchmark
29/06 Perrigo Company plc(NYSE:PRGO) dropped from Russell 1000 Value Benchmark
29/06 Perrigo Company plc(NYSE:PRGO) added to Russell 2000 Dynamic Index
29/06 Perrigo Company plc(NYSE:PRGO) dropped from Russell 1000 Dynamic Index
29/06 Perrigo Company plc(NYSE:PRGO) dropped from Russell Midcap Index
29/06 Perrigo Company plc(NYSE:PRGO) dropped from Russell 1000 Index
24/06 Stada stärkt Geschäft mit Nahrungsergänzungsmitteln durch Zukauf
18/06 FDA Seeks Updated Labeling for Testosterone Therapies
Aucun résultat pour cette recherche